73553-0
Abciximab induced platelet Ab [Interpretation] in Serum or Plasma
Active
Part Description
LP171382-7 Abciximab
Abciximab is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.
Many of the side effects of abciximab are due to its anti-platelet effects. This includes an increased risk of bleeding. The most common type of bleeding due to abciximab is gastrointestinal hemorrhage.
Thrombocytopenia is a rare but known serious risk. Abciximab-induced thrombocytopenia can typically be treated with transfusion of platelets. Abciximab induced thrombocytopenia can last for seven days after initial drug administration.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Abciximab
LOINC Names Get Info
- Fully-Specified Name
- Abciximab induced platelet Ab:
Imp: Pt: Ser/Plas: Nom: - Long Common Name
- Abciximab induced platelet Ab [Interpretation] in Serum or Plasma
- Short Name
- Abciximab ind plt Ab SerPl-Imp
- Display Name
- Abciximab induced platelet Ab [Interp]
- Consumer Name Alpha Get Info
- Abciximab induced platelet antibody, Blood
Part Model Get Info
- Component
- Abciximab induced platelet Ab
LP164289-3
- Analyte
- Abciximab induced platelet Ab
LP164289-3
- Component Numerator
- Abciximab induced platelet Ab
LP164289-3
- Component Numerator Core
- Abciximab
LP171382-7
- Component Numerator Core Suffix
- induced platelet Ab
LP172743-9
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Imp
LP6819-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Nom
LP7750-5
- Method
- NULL
Basic Attributes
- Class
- SERO
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.66 (MIN)
- Order vs. Observation
- Both
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Trombocyty Ab abciximabem indukované: |
| el-GR | Greek (Greece) | Αμπσιξιμάμπη επαγόµενα αντισώματα αιμοπεταλίων: Synonyms: Imp Nom Pt SERO Αιμοπετάλιο Αμπσιξιμάμπη Αντίσωμα επαγόµενα αντισώματα αιμοπεταλίων Ορός Ορός/Πλάσμα Πλάσμα |
| es-ES | Spanish (Spain) | Abciximab Acs. plaquetario inducido: |
| es-MX | Spanish (Mexico) | Abciximab plaquetario inducido: |
| fr-FR | French (France) | Abciximab Plaquettes anticorps induits: |
| it-IT | Italian (Italy) | Abciximab Ab piastrine indotti da: Synonyms: anticorpo Impressione/interpretazione di studio Piastrine Plasma Punto nel tempo (episodio) Siero Siero o Plasma Sierologia (anticorpi e la maggior parte degli ant |
| nl-NL | Dutch (Netherlands) | abciximab geïnduceerd trombocyt As: Synonyms: antistof; |
| ru-RU | Russian (Russian Federation) | Абциксимаб индуцированный пластинка Ат: Synonyms: Антитело Впечатление/интерпретация исследования индуцированные к пластинкам Ат Номинальный; |
| tr-TR | Turkish (Turkey) | Abciximab uyarılmış trombosit Ab: Synonyms: Ak |
| zh-CN | Chinese (China) | 阿昔单抗 诱导型血小板抗体: Synonyms: Ab; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://